Phase I trial of novel HER-2 vaccine for breast cancer initiated.
D001943:Breast Neoplasms / Q000188:drug therapy* / Q000276:immunology*; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology / Q000627:therapeutic use*; D014760:Viral Fusion Proteins
D019496:Cancer Vaccines; D018719:Erb-b2 Receptor Tyrosine Kinases; D014760:Viral Fusion Proteins